Histogen's Series D Round

Histogen raised a round of funding on August 16, 2016. Investors include Huapont Life Sciences.

Histogen is a regenerative medicine company based on naturally-produced products from newborn fibroblasts grown in a bioreactor that mimics the embryonic environment. Histogen has developed a rich pro…

Articles about Histogen's Series D Round: